azathioprine has been researched along with Uterine Diseases in 1 studies
Azathioprine: An immunosuppressive agent used in combination with cyclophosphamide and hydroxychloroquine in the treatment of rheumatoid arthritis. According to the Fourth Annual Report on Carcinogens (NTP 85-002, 1985), this substance has been listed as a known carcinogen. (Merck Index, 11th ed)
azathioprine : A thiopurine that is 6-mercaptopurine in which the mercapto hydrogen is replaced by a 1-methyl-4-nitroimidazol-5-yl group. It is a prodrug for mercaptopurine and is used as an immunosuppressant, prescribed for the treatment of inflammatory conditions and after organ transplantation and also for treatment of Crohn's didease and MS.
Uterine Diseases: Pathological processes involving any part of the UTERUS.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bourgeois-Droin, C | 1 |
| Granier, F | 1 |
| Pedreiro, J | 1 |
| Madinier, V | 1 |
| Grossin, M | 1 |
1 other study available for azathioprine and Uterine Diseases
| Article | Year |
|---|---|
[Vulvovaginal and cervix uteri involvement disclosing pemphigus vulgaris. Efficacy of gold salt therapy].
Topics: Adult; Antirheumatic Agents; Azathioprine; Female; Humans; Organogold Compounds; Pemphigus; Predniso | 1990 |